Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 16 Nov 22 424B3 Prospectus supplement
- 30 Aug 22 424B3 Prospectus supplement
- 30 Aug 22 EFFECT Notice of effectiveness
-
19 Aug 22 F-1 Registration statement (foreign)
ADXN similar filings
- 1 Jun 23 Registration statement (foreign) (amended)
- 11 May 23 Registration statement (foreign) (amended)
- 3 May 23 Registration statement (foreign)
- 19 Aug 22 Registration statement (foreign)
- 7 Jan 22 Registration statement (foreign)
- 6 Jan 21 Registration statement (foreign) (amended)
- 14 Dec 20 Registration statement (foreign)
Filing view
External links
Exhibit 23.4
Consent of Independent Registered Public Accounting Firm
Addex Therapeutics Ltd
Geneva, Switzerland
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 10, 2022, relating to the consolidated financial statements of Addex Therapeutics Ltd appearing in the Company’s Annual Report on Form 20-F for the year ended December 31, 2021.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO AG
Christoph Tschumi Nigel Le Masurier
Zurich, August 19, 2022